Clinical Trial Update: A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma [NA]

View source ↗

Summary

This clinical trial studies neoadjuvant chemoradiotherapy with hypofractionated radiotherapy for esophageal and gastroesophageal junction adenocarcinoma and is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Esophageal Cancer | NA | Status: RECRUITING